Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AACR
AACR
AACR attendees told about tactics to tackle loss of T cell function in CAR T cell treatment
Biopharma Reporter
Mon, 04/19/21 - 11:10 am
Memorial Sloan Kettering
AACR
CAR-T
5 takeaways from AACR, one of the year's top meetings on cancer drugs
BioPharma Dive
Mon, 04/12/21 - 11:34 pm
AACR
CAR-T
Merck
Roche
Sanofi
Synthorx
Eli Lilly
Bristol Myers Squibb
AACR: OncoMyx's engineered rabbit pox virus shows promise in lung cancer model
Fierce Biotech
Mon, 04/12/21 - 10:57 am
AACR
OncoMyx
rabbit pox
non-small cell lung cancer
AZ showcases data for next-generation PARP inhibitor AZD5305
PM Live
Mon, 04/12/21 - 10:39 am
AstraZeneca
AZD5305
Lynparza
AACR
AACR 2021 – Affimed wins, Oncternal loses
EP Vantage
Mon, 04/12/21 - 10:34 am
AACR
Affimed
AFM13
Oncternal
clinical trials
Zentalis keeps the heat on AstraZeneca with early WEE1 data showing a group of 'exceptional' responders
Endpoints
Sun, 04/11/21 - 11:49 pm
Zentalis
ZN-c3
solid tumors
AACR
AACR: In redemption of the PI3K drug class, Bayer's Aliqopa leaps ahead of Gilead's Zydelig in lymphoma
Fierce Pharma
Sun, 04/11/21 - 11:36 pm
AACR
Bayer
Aliqopa
non-Hodgkin lymphoma
follicular lymphoma
Zydelig
Boehringer’s big cancer reveal draws near
EP Vantage
Mon, 03/29/21 - 10:27 am
Boehringer Ingelheim
AACR
cancer
oncology
KRAS
AACR: Minority accrual in clinical trials is a team sport
RAPS.org
Tue, 06/23/20 - 11:36 pm
AACR
clinical trials
diversity
Guardant Health's Blood Cancer Test Detects Early-Stage Colon Cancer
Motley Fool
Mon, 06/22/20 - 08:41 pm
AACR
Guardant Health
clinical trials
diagnostics
colon cancer
Lunar-2
AACR: Attacking pancreatic cancer by thwarting its survival strategies
Fierce Biotech
Mon, 06/22/20 - 10:37 am
pancreatic cancer
AACR
Tyme Technologies
Merck builds case for six-week Keytruda dosing as FDA starts review
Pharmaforum
Mon, 04/27/20 - 07:28 pm
Merck
Keytruda
AACR
FDA
AACR: Roche's Tecentriq, added to Cotellic and Zelboraf, stalls melanoma progression
Fierce Pharma
Mon, 04/27/20 - 09:47 am
Roche
Tecentriq
Cotellic
Zelboraf
melanoma
AACR
#AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions
Endpoints
Mon, 04/27/20 - 09:43 am
Novartis
Incyte
AACR
lung cancer
MET inhibitors
capmatinib
Verastem Oncology announces preliminary data from investigator-initiated study highlighting clinical activity of RAF/MEK and FAK combination in KRAS mutant tumors
Pharmaceutical Business Review
Mon, 04/27/20 - 09:34 am
Verastem
clinical trials
VS-6766
solid tumors
AACR
AACR 2020 preview – no Tigit, but plenty of novel mechanisms
EP Vantage
Wed, 04/22/20 - 10:56 am
AACR
virtual meetings
conferences
Tigit
OX40
Early pancreatic cancer data give Clovis a new path in PARP market
Biopharma Dive
Tue, 04/2/19 - 04:22 pm
pancreatic cancer
Clovis Oncology
AstraZeneca
PARP inhibitors
AACR
Rubraca
Lynparza
Bayer posts early clinical data on follow-up to Loxo’s Vitrakvi
Fierce Biotech
Mon, 04/1/19 - 09:37 pm
Bayer
Loxo Oncology
solid tumors
AACR
Roche's ipatasertib-Tecentriq combo leads to 73% ORR in TNBC patients
BioCentury
Mon, 04/1/19 - 09:32 pm
Roche
clinical trials
Ipatasertib
metastatic triple-negative breast cancer
AACR
AACR: Astellas pads Xospata's AML lead with chemo-beating survival data
Fierce Pharma
Mon, 04/1/19 - 12:38 pm
Astellas
Xospata
acute myeloid leukemia
AML
AACR
Pages
« first
‹ previous
1
2
3
next ›
last »